AZBio Board of Directors
General Manager| Phoenix, Arizona
Nathan serves as the general manager of the Bristol Myers Squibb manufacturing facility in Phoenix. In his role, Nathan is responsible for leading all operations, functions and performance of the 280,000 square foot facility to deliver therapies for pancreatic, non-small cell lung and breast cancers.
Nathan is overseeing the expansion of the existing facility in Phoenix that will transform the site to play a key role in delivering sterile biologic drug product to patients globally. Nathan previously served as the general manager at the Bristol Myers Squibb manufacturing facility in Syracuse.
As a leader with over 20 years of experience in global pharmaceutical and medical device laboratory, quality and operations, Nathan’s diverse expertise includes non-sterile, aseptic and terminal sterilization; vaccine and biologics and device manufacturing. He has led complex manufacturing operational turnarounds and operations excellence deployment. Nathan brings outside-of-the-thinking, technical acumen and high-accountability execution to develop a highly skilled and engaged workforce committed to safety and quality.
Prior to joining Bristol Myers Squibb, Nathan oversaw best practices architecture for Quality, Manufacturing and Technical Operations at Merck where he led the adoption of industry 4.0 mindsets for strategic manufacturing facilities expansions in a $7B capital portfolio. His career spans leadership roles for Smith & Nephew, Pfizer and GlaxoSmithKline in the U.S., Italy and Australia.
Nathan grew up in Australia and received bachelor’s degrees in biochemistry and chemistry from the Swinburne University of Technology in Melbourne.
About Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our people are focused on helping millions of patients around the world in disease areas such as oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Through the Bristol Myers Squibb Foundation, an independent 501(c)(3) charitable organization, we support community-based programs that promote cancer awareness, screening, care and support among high-risk populations in the United States, as well as China, Brazil and sub-Saharan Africa. Our employees around the world work every day to transform patients’ lives through science.